University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA's ...

For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...

About six months after coming out of stealth with $50 million in funding, Latent Labs has released a web-based AI model for programming biology. Latent Labs‘ model has “achieved state-of-the-art in ...

Various approaches to such protein redesign have drawbacks. Traditional methods include time-consuming trial and error efforts, and many models in the emerging field ...

Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including completely new structures never seen before in nature. The technology has huge ...

Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...

This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI's role in designing speedier, more effective clinical trials. Part 2 is ...

Understanding protein–ligand interactions is fundamental to molecular biology and biochemistry. These interactions are at the heart of many cellular processes, from enzyme catalysis to signal ...

The ability to alter proteins to refine control over binding affinity and specificity can create tailored therapeutics with reduced side effects, highly sensitive diagnostic tools, efficient ...